These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28289563)

  • 1. Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride.
    Kiguradze T; Temps WH; Yarnold PR; Cashy J; Brannigan RE; Nardone B; Micali G; West DP; Belknap SM
    PeerJ; 2017; 5():e3020. PubMed ID: 28289563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.
    Corona G; Tirabassi G; Santi D; Maseroli E; Gacci M; Dicuio M; Sforza A; Mannucci E; Maggi M
    Andrology; 2017 Jul; 5(4):671-678. PubMed ID: 28453908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.
    Traish AM; Hassani J; Guay AT; Zitzmann M; Hansen ML
    J Sex Med; 2011 Mar; 8(3):872-84. PubMed ID: 21176115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.
    Kaplan SA; Chung DE; Lee RK; Scofield S; Te AE
    Int J Clin Pract; 2012 Nov; 66(11):1052-5. PubMed ID: 23067029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results.
    Traish AM; Krakowsky Y; Doros G; Morgentaler A
    Sex Med Rev; 2019 Jan; 7(1):95-114. PubMed ID: 30098986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Suicidality and Depression With 5α-Reductase Inhibitors.
    Welk B; McArthur E; Ordon M; Anderson KK; Hayward J; Dixon S
    JAMA Intern Med; 2017 May; 177(5):683-691. PubMed ID: 28319231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
    Lee S; Lee YB; Choe SJ; Lee WS
    Acta Derm Venereol; 2019 Jan; 99(1):12-17. PubMed ID: 30206635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.
    Liu L; Zhao S; Li F; Li E; Kang R; Luo L; Luo J; Wan S; Zhao Z
    J Sex Med; 2016 Sep; 13(9):1297-1310. PubMed ID: 27475241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide.
    Garcia-Argibay M; Hiyoshi A; Fall K; Montgomery S
    JAMA Netw Open; 2022 Dec; 5(12):e2248135. PubMed ID: 36547981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia.
    Traish AM; Haider KS; Doros G; Haider A
    Horm Mol Biol Clin Investig; 2015 Sep; 23(3):85-96. PubMed ID: 26053014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids.
    Othonos N; Marjot T; Woods C; Hazlehurst JM; Nikolaou N; Pofi R; White S; Bonaventura I; Webster C; Duffy J; Cornfield T; Moolla A; Isidori AM; Hodson L; Tomlinson JW
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3316-28. PubMed ID: 32594135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men.
    Amory JK; Anawalt BD; Matsumoto AM; Page ST; Bremner WJ; Wang C; Swerdloff RS; Clark RV
    J Urol; 2008 Jun; 179(6):2333-8. PubMed ID: 18423697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia.
    Shin YS; Karna KK; Choi BR; Park JK
    World J Mens Health; 2019 May; 37(2):157-165. PubMed ID: 30209896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study.
    Wei L; Lai EC; Kao-Yang YH; Walker BR; MacDonald TM; Andrew R
    BMJ; 2019 Apr; 365():l1204. PubMed ID: 30971393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.
    Said MA; Mehta A
    Curr Urol Rep; 2018 Jun; 19(8):65. PubMed ID: 29909472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment.
    Sung HH; Yu J; Kang SJ; Chae MR; So I; Park JK; Lee SW
    World J Mens Health; 2019 May; 37(2):240-248. PubMed ID: 30588787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review.
    Fertig RM; Gamret AC; Darwin E; Gaudi S
    Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression.
    Traish AM; Mulgaonkar A; Giordano N
    Korean J Urol; 2014 Jun; 55(6):367-79. PubMed ID: 24955220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer.
    Tindall DJ; Rittmaster RS
    J Urol; 2008 Apr; 179(4):1235-42. PubMed ID: 18280514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    World J Urol; 2002 Apr; 19(6):413-25. PubMed ID: 12022710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.